Press Releases on January 5, 2023 - EIN Presswire - Press Release Distribution Service

Published on January 5, 2023 - 15:02 GMT

TScan Therapeutics Announces 2023 Clinical Plans and Highlights Recent Progress

Phase 1 umbrella trial of TSC-100 and TSC-101 active in five sites; on track to enroll first two cohorts in 1H 2023 with interim data by end of 2023 Advancing solid tumor program with development of several TCRs for multiple HLAs across multiple targets; …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:02 GMT

Frontier Medicines Announces Advancement of Second and Third Programs Under Global Partnership with AbbVie

SOUTH SAN FRANCISCO, Calif. and BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise undruggable disease-causing targets, today …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:02 GMT

Avalara Appoints Kimberly Deobald as Chief Revenue Officer and Announces New Executive Team Members

Avalara, Inc., a leading provider of cloud-based tax compliance automation for businesses of all sizes, today announced the appointment of global sales and go-to-market leader Kimberly Deobald as its new Chief Revenue Officer. Her responsibilities include …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:02 GMT

The Simply Good Foods Company Reports Fiscal First Quarter 2023 Financial Results and Reaffirms Full Fiscal Year 2023 Net Sales ...

DENVER, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The Simply Good Foods Company SMPL ("Simply Good Foods," or the "Company"), a developer, marketer and seller of branded nutritional foods and snacking products, today reported financial results …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:02 GMT

Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth

Gustavo Mahler hired as the Chief Executive Officer of Ncardia and of Cellistic, and will join the Board of Directors Founder Stefan Braam to assume the role of President and Chief Technical Officer and will remain on the Board of Directors Ncardia and …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:02 GMT

Plymouth Industrial REIT Provides Activity Update for Fourth Quarter 2022; Announces Details for Fourth Quarter Earnings ...

Plymouth Industrial REIT, Inc. PLYM announced its leasing activity for the fourth quarter of 2022. The Company also announced details for its fourth quarter earnings conference call and webcast to be held on February 23, 2023. Jeff Witherell, Chief …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:02 GMT

Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference

Bausch + Lomb Corporation, BLCO ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today announced that Joseph C. Papa, chief executive officer, and Sam Eldessouky, executive vice …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:02 GMT

LogRhythm Enhances Security Analytics with Expanded Security Operations Capabilities

New platform features and integrations enable analysts to quickly detect and remediate threats LogRhythm, the company empowering security teams to navigate the ever-changing threat landscape with confidence, today announced a series of expanded …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:01 GMT

AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AVROBIO, Inc. AVRO, a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that the company has granted an aggregate of 7,500 restricted stock units (RSUs) to one new employee as an …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:02 GMT

Vyluma to Present at the 41st Annual J.P. Morgan Healthcare Conference

BRIDGEWATER, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Vyluma, Inc. ("Vyluma"), a biopharmaceutical company developing multiple assets for the treatment of refractive errors, today announced it will present at the 41st annual J.P. Morgan Healthcare …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:02 GMT

Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH

Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH DUBLIN, Ireland, and Boston MA, January 5, 2023, Amryt AMYT, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:02 GMT

IN8bio Provides INB-200 Clinical Update and Outlines 2023 Pipeline Goals

All three patients exceeded the median progression-free survival (PFS) of seven months with two ongoing responses extending beyond 1.5 years and 1.2 years progression-free, respectively, in initial data from Cohort 2 of the Phase 1 INB-200 trial in newly …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:01 GMT

Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH

BOSTON and LONDON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Orchard Therapeutics ORTX, a global gene therapy leader, today announced the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for OTL-203, a …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:01 GMT

Landos Biopharma Announces $16.7 Million Private Placement Financing

NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. LABP ("Landos" or the "Company"), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced a $ …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:01 GMT

Unicycive Announces Acceptance of Four Abstracts for Presentation at the World Congress of Nephrology 2023

LOS ALTOS, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. UNCY, a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that four abstracts have been accepted for presentation at …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:01 GMT

EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines

– Topline data for Phase 2 DAVIO 2 clinical trial in wet AMD expected in 4Q 2023 – – Enrollment remains on-track in Phase 2 DAVIO 2 clinical trial for wet AMD and Phase 2 PAVIA clinical trial for NPDR – – Full-year 2022 net product revenue estimated to …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:01 GMT

Knology Appoints Christine Reich as Chief Executive Officer

NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Knology, a non-profit research organization, is excited to announce the appointment of Christine Reich, Ph.D., as the organization's new CEO. Reich will lead Knology in its mission to produce practical social …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:01 GMT

Apellis Appoints Leading Retina Specialist Dr. Caroline Baumal as Chief Medical Officer

WALTHAM, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. APLS, a global biopharmaceutical company and leader in complement, today announced that leading retina specialist Caroline Baumal, M.D., has joined Apellis as chief medical …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:01 GMT

Athira Pharma Provides 2023 Pipeline Outlook

Advancing small molecule therapeutic candidates with clinical and preclinical data suggesting potential neuroprotective, neurotrophic, procognitive and disease-modifying effects Fosgonimeton Phase 2/3 LIFT-AD study in mild-to-moderate Alzheimer's …

Distribution channels: Banking, Finance & Investment Industry

Published on January 5, 2023 - 15:01 GMT

Frontier Adds Record Fiber Broadband Customers in Q4 2022

CFO Scott Beasley to Update Investors at Citi's 2023 Communications, Media & Entertainment Conference Frontier FYBR: TL;DR – The Byte-Size Download: Happening: Frontier FYBR reported that it added 75,000 fiber broadband customers in the fourth …

Distribution channels: Banking, Finance & Investment Industry